Elevated pressure causes endothelial dysfunction in mouse carotid arteries by increasing local angiotensin signaling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 308, Issue 4, 2015, Pages H358-H363

  Zhao, Yingzi ^a,b   Flavahan, Sheila ^a   Leung, Susan W ^b   Xu, Aimin ^b   Vanhoutte, Paul M ^b   Flavahan, Nicholas A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ANG II type 1 receptors; Angiotensin II; Endothelium; Hypertension

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; CAPTOPRIL; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PERINDOPRILAT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VALSARTAN; 1,1-DIETHYL-2-HYDROXY-2-NITROSOHYDRAZINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDRAZINE DERIVATIVE; INDOLE DERIVATIVE; NITRIC OXIDE; TETRAZOLE DERIVATIVE; VALINE;

ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY DILATATION; ARTERY WALL; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERTENSION; MALE; MOUSE; MYOGRAPHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASOMOTOR REFLEX; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD PRESSURE; C57BL MOUSE; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CAPTOPRIL; CAROTID ARTERIES; ENDOTHELIUM, VASCULAR; HYDRAZINES; HYPERTENSION; INDOLES; LOSARTAN; MALE; MICE; MICE, INBRED C57BL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TETRAZOLES; VALINE; VALSARTAN; VASODILATION;

EID: 84922880064     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00775.2014     Document Type: Article

References (28)

1. Akazawa H, Yasuda N, Komuro I. Mechanisms and functions of agonist-independent activation in the angiotensin II type 1 receptor. Mol Cell Endocrinol 302: 140–147, 2009.
2. Bader M. Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy. Annu Rev Pharmacol Toxicol 50: 439–465, 2010.
3. Bardy N, Merval R, Benessiano J, Samuel JL, Tedgui A. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta. Evidence for a pressure-induced tissue renin-angiotensin system. Circ Res 79: 70–78, 1996.
4. Brasier AR, Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27: 465–475, 1996.
5. Cassis LA, Police SB, Yiannikouris F, Thatcher SE. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep 10: 93–98, 2008.
6. Delli Gatti C, Osto E, Kouroedov A, Eto M, Shaw S, Volpe M, Luscher TF, Cosentino F. Pulsatile stretch induces release of angiotensin II and oxidative stress in human endothelial cells: effects of ACE inhibition and AT1 receptor antagonism. Clin Exp Hypertens 30: 616–627, 2008.
7. Didion SP, Kinzenbaw DA, Faraci FM. Critical role for CuZn-superox-ide dismutase in preventing angiotensin II-induced endothelial dysfunction. Hypertension 46: 1147–1153, 2005.
8. Flavahan S, Mozayan MM, Lindgren I, Flavahan NA. Pressure-induced maturation of endothelial cells on newborn mouse carotid arteries. Am J Physiol Heart Circ Physiol 305: H321–H329, 2013.
9. Goto K, Fujii K, Onaka U, Abe I, Fujishima M. Renin-angiotensin system blockade improves endothelial dysfunction in hypertension. Hypertension 36: 575–580, 2000.
10. Huang A, Sun D, Kaley G, Koller A. Superoxide released to high intra-arteriolar pressure reduces nitric oxide-mediated shear stress- and agonist-induced dilations. Circ Res 83: 960–965, 1998.
11. Jurva JW, Phillips SA, Syed AQ, Syed AY, Pitt S, Weaver A, Gutterman DD. The effect of exertional hypertension evoked by weight lifting on vascular endothelial function. J Am Coll Cardiol 48: 588–589, 2006.
12. Lemarie CA, Esposito B, Tedgui A, Lehoux S. Pressure-induced vascular activation of nuclear factor-kappaB: role in cell survival. Circ Res 93: 207–212, 2003.
13. Lemarie CA, Tharaux PL, Esposito B, Tedgui A, Lehoux S. Transforming growth factor-alpha mediates nuclear factor kappaB activation in strained arteries. Circ Res 99: 434–441, 2006.
14. Li JM, Wheatcroft S, Fan LM, Kearney MT, Shah AM. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation. Circulation 109: 1307–1313, 2004.
15. Lu X, Choy JS, Zhang Z, Wassall CD, Guo X, Kemple MD, Kassab GS. Effects of local mechanical stimulation on coronary artery endothelial function and angiotensin II type 1 receptor in pressure or flow-overload. J Hypertens 31: 720–729, 2013.
16. Lüscher TF. Endothelial dysfunction: the role and impact of the renin-angiotensin system. Heart 84: 120–122, 2000.
17. Millgard J, Lind L. Acute hypertension impairs endothelium-dependent vasodilation. Clin Sci (Lond) 94: 601–607, 1998.
18. Miura S, Kiya Y, Kanazawa T, Imaizumi S, Fujino M, Matsuo Y, Karnik SS, Saku K. Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. Mol Endocrinol 22: 139–146, 2008.
19. Nguyen Dinh Cat A, Touyz RM. A new look at the renin-angiotensin system–focusing on the vascular system. Peptides 32: 2141–2150, 2011.
20. Nowicki PT, Flavahan S, Hassanain H, Mitra S, Holland S, Gold-schmidt-Clermont PJ, Flavahan NA. Redox signaling of the arteriolar myogenic response. Circ Res 89: 114–116, 2001.
21. Paniagua OA, Bryant MB, Panza JA. Transient hypertension directly impairs endothelium-dependent vasodilation of the human microvascula-ture. Hypertension 36: 941–944, 2000.
22. Phillips SA, Das E, Wang J, Pritchard K, Gutterman DD. Resistance and aerobic exercise protects against acute endothelial impairment induced by a single exposure to hypertension during exertion. J Appl Physiol 110: 1013–1020, 2011.
23. Qin Y, Yasuda N, Akazawa H, Ito K, Kudo Y, Liao CH, Yamamoto R, Miura S, Saku K, Komuro I. Multivalent ligand-receptor interactions elicit inverse agonist activity of AT(1) receptor blockers against stretch-induced AT(1) receptor activation. Hypertens Res 32: 875–883, 2009.
24. Ungvari Z, Wolin MS, Csiszar A. Mechanosensitive production of reactive oxygen species in endothelial and smooth muscle cells: role in microvascular remodeling? Antioxid Redox Signal 8: 1121–1129, 2006.
25. Varin R, Mulder P, Tamion F, Richard V, Henry JP, Lallemand F, Lerebours G, Thuillez C. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin. Circulation 102: 351–356, 2000.
26. Vecchione C, Carnevale D, Di Pardo A, Gentile MT, Damato A, Cocozza G, Antenucci G, Mascio G, Bettarini U, Landolfi A, Iorio L, Maffei A, Lembo G. Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway. Hypertension 54: 1028–1034, 2009.
27. Zhou Y, Dirksen WP, Babu GJ, Periasamy M. Differential vasocon-strictions induced by angiotensin II: role of AT1 and AT2 receptors in isolated C57BL/6J mouse blood vessels. Am J Physiol Heart Circ Physiol 285: H2797–H2803, 2003.
28. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M, Nagai T, Fukamizu A, Umemura S, Iiri T, Fujita T, Komuro I. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 6: 499–506, 2004.